贛鋒鋰業(01772.HK)擬投資建設年產7000噸金屬鋰及鋰材項目
格隆匯 4 月 8日丨贛鋒鋰業(01772.HK)公佈,公司與宜春經濟技術開發區管理委員會於2021年4月8日簽署了《投資合同書》,基於公司在江西省宜春市已建有全球最大的金屬鋰生產基地,該地具備公司擴產和發展的優越條件,基於雙方共同的發展願景,經雙方友好協商,公司決定在管委會所轄範圍內分期投資建設年產7,000噸金屬鋰及鋰材項目,新建金屬鋰熔鹽電解、金屬鋰低温真空蒸餾提純、鋰系列合金、固態鋰電池負極材料等生產線,具體投資金額以實際項目投資為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.